Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation

 

    For the Years Ended
December 31,		  
    2019     2018  
Research and development   $ 915,075     $ 2,583,251  
General and administrative     1,694,295       1,735,742  
Total   $ 2,609,370     $ 4,318,993  

Schedule of stock option activity

 

                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     5,691,414       3,124,941     $ 1.16     $ 0.73     $ 0.73       6.87     $   -  
Granted     860,000       -       -       -       -       -       -  
Exercised     (602,533 )     -       -       -       -       -       -  
Cancelled     (460,599 )     -       -       -       -       -       -  
Balance – December 31, 2018     5,488,282       4,384,294     $ 2.10     $ 1.32     $ 1.32       5.80     $ -  
Granted     2,779,000       -       -       -       -       -       -  
Exercised     (441,210 )     -       -       -       -       -       -  
Cancelled     (193,714 )     -       -       -       -       -       -  
Balance – December 31, 2019     7,632,358       4,542,144     $ 2.21     $ 1.57     $ 1.57       6.44     $ 2,364,422  

Schedule of stock options outstanding and exercisable

 

Grant Price     Weighted Average     Total     Number     Weighted Average
Remaining Contractual		  
From     To     Exercise Price     Outstanding     Exercisable       Term  
$ 0.05     $ 2.02     $ 0.89       3,290,357       3,086,190       4.32 years  
$ 2.40     $ 4.60     $ 2.47       3,649,001       998,021       8.64 years  
$ 5.30     $ 8.86     $ 6.62       693,000       457,933       8.36 years  
                  Totals       7,632,358       4,542,144          

Schedule of warrants activity

                Weighted Average      
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2017     4,533,020       4,517,395     $ 1.85     $ 1.85     $ 1.00       3.21     $ -  
Granted     780,500       -       -       -       -       -       -  
Exercised     (349,315 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – December 31, 2018     4,964,205       4,964,205     $ 2.39     $ 2.39     $ 1.14       2.27     $ -  
Granted     -       -       -       -       -       -       -  
Exercised     (50,000 )     -       -       -       -       -       -  
Cancelled     (6,982 )     -       -       -       -       -       -  
Balance – December 31, 2019     4,907,223       4,907,223     $ 2.40     $ 2.40     $ 1.11       1.55     $ 1,077,594